Tags

Type your tag names separated by a space and hit enter

Development of morin/hydroxypropyl-β-cyclodextrin inclusion complex: Enhancement of bioavailability, antihyperalgesic and anti-inflammatory effects.
Food Chem Toxicol. 2019 Apr; 126:15-24.FC

Abstract

Morin is a flavonoid has been reported with several pharmacological effects such as, antioxidant, anti-inflammatory, anticancer, antidiabetic, etc. However, morin has low solubility in water, which decreases the bioavailability and limits its clinical application. In this way, to improve the pharmaceutical properties, morin was complexed in hydroxypropyl-β-cyclodextrin (HP-β-CD) and its oral bioavailability and anti-inflammatory effects were evaluated. Initially, a phase solubility study was performed, which showed that HP-β-CD would be the better cyclodextrin for the formation of complexes with morin. The morin/HP-β-CD inclusion complex (1:1) was prepared by freeze-drying method. The sample obtained was characterized by DSC, FTIR, PXRD, SEM and 1H NMR techniques, evidencing the formation of morin/HP-β-CD inclusion complex. In addition, complexation efficiency (98.3%) and loading content (17.63%), determined by HPLC demonstrated that morin was efficiently complexed in HP-β-CD. In vitro dissolution study confirmed that morin/HP-β-CD inclusion complex increased the solubility and dissolution rate of morin. The oral bioavailability of the morin/HP-β-CD complex and free morin were evaluated through a pharmacokinetic study in rat plasma. The oral bioavailability of morin complexed with HP-β-CD was increased by 4.20 times compared with the free morin. Hyperalgesia induced by carrageenan and carrageenan-induced pleurisy were carried out in mice to evaluate the antihyperalgesic and anti-inflammatory activities of free morin and inclusion complex. Morin/HP-β-CD inclusion complex showed antihyperalgesic effect in inflammatory pain model and anti-inflammatory effect decreasing leukocyte migration and TNF-α levels at a lower dose than free morin. Therefore, the morin/HP-β-CD inclusion complex improved the solubility, dissolution rate, oral bioavailability, antihyperalgesic and anti-inflammatory effects of morin. In this way, the morin/HP-β-CD inclusion complex exhibits potential for development of new pharmaceutical product for future clinical applications.

Authors+Show Affiliations

Department of Pharmacy, Federal University of Sergipe, Elze, São Cristóvão, SE, 49100-000, Brazil.Department of Pharmacy, Federal University of Sergipe, Elze, São Cristóvão, SE, 49100-000, Brazil.Department of Pharmacy, Federal University of Sergipe, Elze, São Cristóvão, SE, 49100-000, Brazil.Department of Pharmacy, Federal University of Sergipe, Elze, São Cristóvão, SE, 49100-000, Brazil.Department of Pharmacy, Federal University of Sergipe, Elze, São Cristóvão, SE, 49100-000, Brazil.Department of Pharmacy, Federal University of Sergipe, Elze, São Cristóvão, SE, 49100-000, Brazil. Electronic address: saranflora04@gmail.com.Department of Physiology, Federal University of Sergipe, São Cristóvão, SE, Brazil.Faculty of Pharmacy, Federal University of Goiás, Goiânia, GO, Brazil.Department of Pharmacy, Federal University of Sergipe, Elze, São Cristóvão, SE, 49100-000, Brazil.Center for Studies and Research on Medicinal Plants, Federal University of San Francisco Valley, PE, Brazil.Department of Physiology, Federal University of Sergipe, São Cristóvão, SE, Brazil.Department of Physiology, Federal University of Sergipe, São Cristóvão, SE, Brazil.Department of Pharmacy, Federal University of Sergipe, Elze, São Cristóvão, SE, 49100-000, Brazil. Electronic address: adriasa2001@yahoo.com.br.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

30738132

Citation

Lima, Bruno Dos Santos, et al. "Development of Morin/hydroxypropyl-β-cyclodextrin Inclusion Complex: Enhancement of Bioavailability, Antihyperalgesic and Anti-inflammatory Effects." Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association, vol. 126, 2019, pp. 15-24.
Lima BDS, Campos CA, da Silva Santos ACR, et al. Development of morin/hydroxypropyl-β-cyclodextrin inclusion complex: Enhancement of bioavailability, antihyperalgesic and anti-inflammatory effects. Food Chem Toxicol. 2019;126:15-24.
Lima, B. D. S., Campos, C. A., da Silva Santos, A. C. R., Santos, V. C. N., Trindade, G. D. G. G., Shanmugam, S., Pereira, E. W. M., Marreto, R. N., Duarte, M. C., Almeida, J. R. G. D. S., Quintans, J. S. S., Quintans, L. J., & Araújo, A. A. S. (2019). Development of morin/hydroxypropyl-β-cyclodextrin inclusion complex: Enhancement of bioavailability, antihyperalgesic and anti-inflammatory effects. Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association, 126, 15-24. https://doi.org/10.1016/j.fct.2019.01.038
Lima BDS, et al. Development of Morin/hydroxypropyl-β-cyclodextrin Inclusion Complex: Enhancement of Bioavailability, Antihyperalgesic and Anti-inflammatory Effects. Food Chem Toxicol. 2019;126:15-24. PubMed PMID: 30738132.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Development of morin/hydroxypropyl-β-cyclodextrin inclusion complex: Enhancement of bioavailability, antihyperalgesic and anti-inflammatory effects. AU - Lima,Bruno Dos Santos, AU - Campos,Caio de Alcântara, AU - da Silva Santos,Anna Clara Ramos, AU - Santos,Victória Caroline Nunes, AU - Trindade,Gabriela das Graças Gomes, AU - Shanmugam,Saravanan, AU - Pereira,Erik Willyame Menezes, AU - Marreto,Ricardo Neves, AU - Duarte,Marcelo Cavalcante, AU - Almeida,Jackson Roberto Guedes da Silva, AU - Quintans,Jullyana de Souza Siqueira, AU - Quintans,Lucindo José,Jr AU - Araújo,Adriano Antunes de Souza, Y1 - 2019/02/06/ PY - 2018/10/30/received PY - 2019/01/29/revised PY - 2019/01/31/accepted PY - 2019/2/10/pubmed PY - 2019/5/7/medline PY - 2019/2/10/entrez KW - Anti-inflammatory KW - Antihyperalgesic KW - Bioavailability KW - Hydroxypropyl-β-cyclodextrin KW - Morin SP - 15 EP - 24 JF - Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association JO - Food Chem Toxicol VL - 126 N2 - Morin is a flavonoid has been reported with several pharmacological effects such as, antioxidant, anti-inflammatory, anticancer, antidiabetic, etc. However, morin has low solubility in water, which decreases the bioavailability and limits its clinical application. In this way, to improve the pharmaceutical properties, morin was complexed in hydroxypropyl-β-cyclodextrin (HP-β-CD) and its oral bioavailability and anti-inflammatory effects were evaluated. Initially, a phase solubility study was performed, which showed that HP-β-CD would be the better cyclodextrin for the formation of complexes with morin. The morin/HP-β-CD inclusion complex (1:1) was prepared by freeze-drying method. The sample obtained was characterized by DSC, FTIR, PXRD, SEM and 1H NMR techniques, evidencing the formation of morin/HP-β-CD inclusion complex. In addition, complexation efficiency (98.3%) and loading content (17.63%), determined by HPLC demonstrated that morin was efficiently complexed in HP-β-CD. In vitro dissolution study confirmed that morin/HP-β-CD inclusion complex increased the solubility and dissolution rate of morin. The oral bioavailability of the morin/HP-β-CD complex and free morin were evaluated through a pharmacokinetic study in rat plasma. The oral bioavailability of morin complexed with HP-β-CD was increased by 4.20 times compared with the free morin. Hyperalgesia induced by carrageenan and carrageenan-induced pleurisy were carried out in mice to evaluate the antihyperalgesic and anti-inflammatory activities of free morin and inclusion complex. Morin/HP-β-CD inclusion complex showed antihyperalgesic effect in inflammatory pain model and anti-inflammatory effect decreasing leukocyte migration and TNF-α levels at a lower dose than free morin. Therefore, the morin/HP-β-CD inclusion complex improved the solubility, dissolution rate, oral bioavailability, antihyperalgesic and anti-inflammatory effects of morin. In this way, the morin/HP-β-CD inclusion complex exhibits potential for development of new pharmaceutical product for future clinical applications. SN - 1873-6351 UR - https://www.unboundmedicine.com/medline/citation/30738132/Development_of_morin/hydroxypropyl_β_cyclodextrin_inclusion_complex:_Enhancement_of_bioavailability_antihyperalgesic_and_anti_inflammatory_effects_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0278-6915(19)30049-3 DB - PRIME DP - Unbound Medicine ER -